A Cost-Per-Responder Analysis of Secukinumab Compared with Ustekinumab in Saudi Arabia: Results from the Clear Study of Patients With Moderate to Severe Psoriasis
Al Howimel, M, Al Jufan, K, AlAlwan, A, Alshehri, N, Al Mudaiheem, H, Al Amri, A, Al Hamdan, H, Zakaria, N, Al Kateb, L, Gilloteau, I, Graham, CN, Sekharan, MVolume:
21
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2018.07.808
Date:
September, 2018
File:
PDF, 63 KB
english, 2018